Prevention of COVID-19 Infection to Severe Pneumonia or ARDS

NCT04569227 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Covid19 Pneumonia

Interventions

DRUG: EC-18
DRUG: Placebo

Sponsor

Enzychem Lifesciences Corporation